Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Torben Smidt-Hansen"'
Autor:
Nina Breinholt Staerke, Torben Smidt-Hansen, Leni Oldenborg, Torben Tranborg Jensen, Ulla Møller Weinreich, Shakil Shakar, Christian Wejse, Ole Hilberg, Andreas Fløe
Publikováno v:
International Journal of Infectious Diseases, Vol 102, Iss , Pp 352-356 (2021)
Background: Screening for TB (tuberculosis) among socially marginalized citizens has been implemented in many urban areas in countries with a low incidence of TB, including Denmark. This study aims to describe the findings of the screening programs f
Externí odkaz:
https://doaj.org/article/1b40630c203c42f0bd9d403d3db2eb6b
Autor:
Torben Smidt-Hansen, Andreas Fløe, Nina Breinholt Stærke, Torben Tranborg Jensen, Christian Wejse, Ole Hilberg, Ulla Møller Weinreich, Shakil Shakar, Leni Oldenborg
Publikováno v:
Staerke, N B, Smidt-Hansen, T, Oldenborg, L, Jensen, T T, Weinreich, U M, Shakar, S, Wejse, C, Hilberg, O & Fløe, A 2021, ' High yield from repeated testing for tuberculosis among high-risk citizens in Denmark ', International Journal of Infectious Diseases, vol. 102, pp. 352-356 . https://doi.org/10.1016/j.ijid.2020.10.076
International Journal of Infectious Diseases, Vol 102, Iss, Pp 352-356 (2021)
International Journal of Infectious Diseases, Vol 102, Iss, Pp 352-356 (2021)
BACKGROUND: Screening for tuberculosis among socially marginalized citizens have been implemented in many urban areas in low-incidence countries including Denmark. This study aims to describe the findings of the screening programs for tuberculosis (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b38f87a6cd37d55f751b1c4bec150c3
https://vbn.aau.dk/da/publications/3d85323c-4a6a-48c4-a692-1d015573bd90
https://vbn.aau.dk/da/publications/3d85323c-4a6a-48c4-a692-1d015573bd90
Publikováno v:
Tuberculosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea70904d54b0dfdaf8c609158a1b582c
https://doi.org/10.1183/13993003.congress-2019.pa4622
https://doi.org/10.1183/13993003.congress-2019.pa4622
Publikováno v:
BMJ Case Rep
Smidt-Hansen, T & Rasmussen, T R 2018, ' Case of a missed airway stent migration ', B M J Case Reports, vol. 11, no. 1, e226533 . https://doi.org/10.1136/bcr-2018-226533
Smidt-Hansen, T & Rasmussen, T R 2018, ' Case of a missed airway stent migration ', B M J Case Reports, vol. 11, no. 1, e226533 . https://doi.org/10.1136/bcr-2018-226533
This case report describes a rare complication to stent management of airway compression. An 84- year-old man was admitted to the outpatient clinic with haemoptysis, cough and dyspnoea. A CT scan showed an intraluminal, non-occluding tumour close to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da53d2734d6d75f3e26879d53a182567
https://europepmc.org/articles/PMC6301453/
https://europepmc.org/articles/PMC6301453/
Publikováno v:
Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324
Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC) : results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324
Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC) : results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324
BACKGROUND: Interleukin-2 (IL2)-based immunotherapy is curative for a small subset of patients with metastatic renal-cell carcinoma (mRCC). Preclinical data suggests that bevacizumab (BEV), a humanized anti-VEGF monoclonal antibody, has potential imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140f3802d1a95917488d380c8e4d37fe
https://pubmed.ncbi.nlm.nih.gov/29392960
https://pubmed.ncbi.nlm.nih.gov/29392960
Publikováno v:
Smidt-Hansen, T, Folkmar, T B, Fode, K, Agerbaek, M & Donskov, F 2013, ' Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma ', Journal of Oral and Maxillofacial Surgery, vol. 71, no. 9, pp. 1532-40 . https://doi.org/10.1016/j.joms.2013.03.019
To investigate the efficacy and safety of zoledronic acid (ZA) combined with targeted therapy (TT).A retrospective study was performed in patients with metastatic renal cell carcinoma treated with ZA and TT.Twenty-one patients received ZA and TT to p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e17ff8f35bf92dfeacad2812c57cf378
https://doi.org/10.1016/j.joms.2013.03.019
https://doi.org/10.1016/j.joms.2013.03.019
Publikováno v:
Journal of Clinical Oncology. 34:4563-4563
4563Background: The potential benefit of combining the antiangiogenic agent bevacizumab (BEV) with Interleukin-2/Interferon-alpha (IL2/IFN) immunotherapy is unknown. This randomized, open-label, ph...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af9a954ee6a9dcb2b153aca1f836a458
https://doi.org/10.1200/jco.2016.34.15_suppl.4563
https://doi.org/10.1200/jco.2016.34.15_suppl.4563